opening price, page-2

Hi Footsie, i didn't think the "wonder spike" would come so soon but since we are here I'll tip $1.80 open.

GSK has Relenza in full production, look for news about increased production capacity as that would give away the orders they are getting or expect to get.

In my mind Relenza is just the tip of the iceberg with Biota. LANI in my opinion could be worth much more, and it could possibly be the market leader due to it's many advanages. Not in market yet but Phase III to be released mid-year.